捷迈邦美 2026年季度报告

Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). As of April 23, 2026, 193,462,482 shares of the registrant’s $.01 par value common stock were outstanding. ZIMMER BIOMET HOLDINGS, INC.INDEX TO FORM 10-Q Part I - Financial Information Item 1.Financial Statements (unaudited)Condensed Consolidated Statements of Earnings for the Three Months Ended March 31, 2026 and 2025Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2026 33and 20254Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 20255Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2026and 20256Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 20257Notes to Interim Condensed Consolidated Financial Statements8 Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations Item 3.Quantitative and Qualitative Disclosures About Market Risk Part II - Other Information Item 1.Legal ProceedingsItem 1A.Risk FactorsItem 2.Unregistered Sales of Equity Securities and Use of ProceedsItem 3.Defaults Upon Senior SecuritiesItem 4.Mine Safety DisclosuresItem 5.Other InformationItem 6.ExhibitsSignatures ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF EARNINGS ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS ZIMMER BIOMET HOLDINGS, INC. AND SUBSIDIARIESNOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 1. Basis of Presentation The financial data presented herein is unaudited and should be read in conjunction with the consolidated financial statementsand accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 20, In our opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting ofonly normal recurring adjustments, necessary for a fair statement of the financial position, results of operations and cash flows forthe interim periods presented. The December 31, 2025 condensed consolidated balance sheet data was derived from audited Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the actual amounts. As aresult, the sum of the components may not equal the total amount reported in millions due to rounding. In addition, certain columnsand rows within tables may not sum to the totals due to the use of rounded numbers. Percentages presented are calculated from the The words “we,” “us,” “our” and similar words, “Zimmer Biomet” and “the Company” refer to Zimmer Biomet Holdings, Inc.and its subsidiaries. “Zimmer Biomet Holdings” refers to the parent company only. We reclassified certain prior period amounts to conform to the current period presentation. 2. Significant Accounting Policies Use of Estimates- The accompanying unaudited condensed consolidated financial statements are prepared in conformity withGAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosureof contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during Accounting Pronouncements Not Yet Adopted- In November 2024, the Financial Accounting Standards Board ("FASB")issued Accounting Standards Update ("ASU") 2024-03, Disaggregation of Income Statement Expenses, which is an amendment toASC Topic 220 - Comprehensive Income. The ASU improves financial reporting by requiring disclosure of additional informationabout specific expense categories included in the expense captions presented on the income sta